NSE: CERA | BSE: 532443

Mid-range Performer

Download real time

6122.50 -57.50 (-0.93%)

High volume today

NSE 24 Sep, 2025 3:31 PM (IST)

7,896.5

Market Cap

Above industry Median

Beta 1Year

Average volatility

Cera Sanitaryware Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for CERA, BSE:532443 Cera Sanitaryware Ltd.

Search Inside the pdf :

Cera Sanitaryware Ltd.

08 Aug 2025

6122.50

-0.93%

Result Update:Cera Sanitary.

Buy: Cera Sanitaryware Ltd.

Axis Direct

We maintain our BUY recommendation on the stock.

Cera Sanitaryware Ltd. is trading at high day volume of 35549.00000.

Cera Sanitaryware Ltd.

08 Aug 2025

6122.50

-0.93%

Stable performance, management retains guidance; upgrading to a Buy

Buy: Cera Sanitaryware Ltd.

Target

Anand Rathi

Amidst the subdued demand environment, Cera Sanitaryware reported a stable performance. Revenue grew 5.4% y/y to Rs4.2bn, largely supported by faucets as sanitaryware revenue was flat.

Cera Sanitaryware Ltd. has lost -25.79% in the last 1 Year

Cera Sanitaryware Ltd.

07 Aug 2025

6122.50

-0.93%

Cera Sanitaryware: Q1FY26 Result Review

Hold: Cera Sanitaryware Ltd.

Target

IDBI Capital

Cera Sanitaryware Ltd.'s (Cera) Q1FY26 performance was in-line with our estimate on net sales front, while margins disappointed. The industry is facing subdued market condition from the last six to seven quarters. Consequently, there has been no price increase in the sector for some time, especially in Sanitary ware. However, the management guided that the long-term outlook is expected to stay strong, supported by continued formalization of the sector, rising aspiration of the consumers, and supporting policy initiatives such as urban redevelopment, housing schemes, and sanitation infrastructure. The...

Cera Sanitaryware Ltd. is trading at high day volume of 35549.00000.

Cera Sanitaryware Ltd.

07 Aug 2025

6122.50

-0.93%

Cera Sanitaryware (CRS IN) Q1FY26 Result Update Focus...

Accumulate: Cera Sanitaryware Ltd.

Recommendation Target

Prabhudas Lilladhar

increase in employee cost and B2B contribution. CRS aims to outperform the industry by 6-7%, with EBITDA margin of 15-16% by the end of FY26. The company continues to hold off its sanitaryware expansion plans until the demand environment improves. We estimate revenue/ EBITDA/PAT CAGR of 11.4%/12.2%/10.7% over FY25-27E. We downward revise FY26/FY27E earnings estimate by 1.9%/2.8% and reduce TP to Rs7,178 (Rs7,389 earlier), based on 30x FY27E earnings. Maintain Accumulate' rating....

Cera Sanitaryware Ltd. has lost -25.79% in the last 1 Year

Cera Sanitaryware Ltd.

16 Jul 2025

6122.50

-0.93%

Initiating Coverage:Cera Sanitary.

Buy: Cera Sanitaryware Ltd.

Axis Direct

We initiate coverage of Cera Sanitaryware Ltd. with a BUY recommendation and a target price of Rs 8,500/share, implying a potential upside of 31% from the CMP.

Cera Sanitaryware Ltd. has lost -25.79% in the last 1 Year

Cera Sanitaryware Ltd.

10 May 2025

6122.50

-0.93%

Cera Sanitaryware (CRS IN) Q4FY25 Result Update Focus...

Buy: Cera Sanitaryware Ltd.

Target

Prabhudas Lilladhar

the retail space for CRS. CRS reported 5.8% growth in revenue with 130bps expansion in EBITDA margin in Q4FY25 due to cost management and operational leverage. CRS is expected to outperform the industry by 6-7%, with EBITDA margin of 15-16% by the end of FY26. The company continues to hold...

Cera Sanitaryware Ltd. is trading at high day volume of 35549.00000.

Cera Sanitaryware Ltd.

27 Mar 2025

6122.50

-0.93%

Cera Sanitaryware (CRS IN) Visit Update Focus on...

Buy: Cera Sanitaryware Ltd.

Recommendation

Prabhudas Lilladhar

to gain insights into demand, competition, capacity expansion plans, and product diversification strategies for the near to long term. We believe demand challenges in the bathware segment will continue in the near term. However, the management expects demand to revive in Q2FY26. The company aims to drive growth through product diversification, focusing on premium offerings. In the long term, growth is expected to come from premium products, which are targeted to contribute to 10% of revenue in the...